Scarica l'app Stockscreener
7.64
1.06%
0.06
Precedente Chiudi:
$7.58
Aprire:
$7.64
Volume 24 ore:
71,543
Relative Volume:
0.30
Capitalizzazione di mercato:
$205.42M
Reddito:
$331.52M
Utile/perdita netta:
$-52.69M
Rapporto P/E:
-3.3956
EPS:
-2.25
Flusso di cassa netto:
$-14.47M
1 W Prestazione:
+21.59%
1M Prestazione:
+10.69%
6M Prestazione:
-28.14%
1 anno Prestazione:
-38.67%
Intervallo 1D:
$7.5998
$7.75
Intervallo di 1 settimana:
$5.8502
$7.76
Portata 52W:
$5.70
$13.33
Inogen Inc Stock (INGN) Company Profile
Nome
Inogen Inc
Settore
Industria
Telefono
805-562-0500
Indirizzo
859 WARD DRIVE, GOLETA, CA
Confronta INGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
7.64 | 190.36M | 331.52M | -52.69M | -14.47M | -2.25 |
|
ABT
Abbott Laboratories
|
129.02 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.65 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
376.58 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.84 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.56 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-16 | Iniziato | B. Riley Securities | Buy |
| 2025-05-22 | Aggiornamento | Needham | Hold → Buy |
| 2024-02-15 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Downgrade | Needham | Buy → Hold |
| 2023-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Aggiornamento | Needham | Hold → Buy |
| 2021-11-02 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Downgrade | Needham | Buy → Hold |
| 2020-05-06 | Reiterato | Needham | Buy |
| 2019-11-06 | Aggiornamento | Needham | Hold → Buy |
| 2019-09-13 | Reiterato | Piper Jaffray | Overweight |
| 2019-08-08 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Downgrade | Stifel | Buy → Hold |
| 2019-08-07 | Downgrade | Needham | Buy → Hold |
| 2019-06-28 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Reiterato | Needham | Strong Buy |
| 2019-02-27 | Reiterato | Needham | Strong Buy |
| 2018-11-20 | Aggiornamento | Needham | Buy → Strong Buy |
| 2018-11-07 | Reiterato | Needham | Buy |
| 2018-09-10 | Downgrade | Needham | Strong Buy → Buy |
| 2018-08-22 | Ripresa | Stifel | Buy |
| 2018-08-08 | Reiterato | Needham | Strong Buy |
| 2018-06-06 | Iniziato | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Reiterato | Needham | Strong Buy |
| 2018-02-28 | Reiterato | Needham | Strong Buy |
Mostra tutto
Inogen Inc Borsa (INGN) Ultime notizie
Regression analysis insights on Inogen Inc. performance2025 Institutional Moves & Weekly Watchlist for Consistent Profits - Newser
Short interest data insights for Inogen Inc.2025 Year in Review & Long-Term Capital Growth Ideas - Newser
Inogen Inc. stock prediction for this weekWeekly Trade Report & Verified Chart Pattern Signals - Newser
XTX Topco Ltd Purchases New Holdings in Inogen, Inc (NASDAQ:INGN) - Defense World
What indicators show strength in Inogen Inc.Recession Risk & Low Drawdown Investment Ideas - Newser
Inogen Inc’s Earnings Call Highlights Growth and Innovation - TipRanks
What technical models suggest about Inogen Inc.’s comebackFast Movement Forecast for Trading Success - Newser
Tools to assess Inogen Inc.’s risk profileChart Based Entry Tool for ROI Traders - Newser
Inogen, Inc. (NASDAQ:INGN) Q2 2025 Earnings Call Transcript - Insider Monkey
US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD - Yahoo Finance
How to build a custom watchlist for Inogen Inc.Short Term Gain Strategy with AI Logic - Newser
Why Inogen Inc. stock attracts strong analyst attentionFree Accurate Buy Point for Momentum Stocks - Newser
How Interest Rate Changes Impact Inogen Inc. Stock PerformanceMachine Learning Stock Price Forecast Tool - Newser
Statistical indicators supporting Inogen Inc.’s strengthFree Daily Chart Pattern Stock Forecast - Newser
Is now a turning point for Inogen Inc.Forecasting Stock Moves with AI Insights - Newser
Inogen Second Quarter 2025 Earnings: Beats Expectations - ca.finance.yahoo.com
Live market analysis of Inogen Inc.Chart Driven Opportunity Scanner with Alerts - Newser
Inogen's Q2 Earnings Beat: A Glimpse of Strategic Turnaround Amid Industry Headwinds? - AInvest
Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y - MSN
Inogen 2025 Q2 Earnings Net Loss Narrows 25.7% - AInvest
Inogen's Q2 2025 Earnings and Strategic Product Innovation: A Pathway to Margin Expansion and Market Leadership - AInvest
Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates - NewsBreak: Local News & Alerts
How Inogen Inc. stock performs during market volatilityCapital Growth Summary Over Five Years - Newser
Can Inogen Catch Its Second Breath After An Upbeat Outlook? - RTTNews
Inogen: Q2 Earnings Snapshot - Connecticut Post
Inogen Q2 2025 slides: B2B growth offsets consumer segment decline By Investing.com - Investing.com South Africa
Inogen Inc (INGN) Q2 2025 Earnings Call Highlights: Steady Growth Amidst Challenges - Yahoo Finance
Predicting Inogen Inc. trend using moving averagesFree Access to Real-Time Trade Insights - Newser
Inogen Inc (INGN) Q2 2025 Earnings Call Highlights: Steady Growth Amidst Challenges By GuruFocus - Investing.com Canada
Inogen Reports Growth and Raises Revenue Outlook - TipRanks
Inogen Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Inogen reports Q2 EPS (15c), one estimate (9c) - TipRanks
What’s next for Inogen Inc. stock priceHistorical Stock Summary and ROI Review - Newser
Inogen's Turnaround Momentum and Path to EBITDA Breakeven in 2025 - AInvest
Inogen Inc earnings beat by $0.12, revenue topped estimates - Investing.com South Africa
Inogen Q2 revenue up 4%, beats estimates, raises FY revenue guidance - MarketScreener
Inogen Announces Second Quarter 2025 Financial Results - Yahoo Finance
Inogen Inc Azioni (INGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Inogen Inc Azioni (INGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 03 '25 |
Buy |
8.32 |
3,000 |
24,960 |
47,646 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '25 |
Option Exercise |
0.00 |
28,333 |
0 |
44,387 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 03 '25 |
Buy |
8.56 |
11,709 |
100,245 |
70,274 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '24 |
Option Exercise |
0.00 |
28,333 |
0 |
28,333 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '24 |
Option Exercise |
0.00 |
31,565 |
0 |
31,565 |
0.18%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):